sarah.morrison said:Short answer: it depends on your starting point
Gonna push back on this one. GLP-1 and atrial fibrillation risk is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.
Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.
Adding my data to this GLP-1 and atrial discussion:
| Metric | Baseline | Month 3 | Month 6 |
|---|---|---|---|
| Weight | 256 lbs | 226 lbs | 201 lbs |
| A1C | 7.0% | 5.8% | 5.2% |
| hsCRP | 5.0 | 2.0 | 0.6 |
Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.
claudia_zurich — wow. This community is amazing.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesSlightly tangential to GLP-1 and atrial but marco_milano reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.